MARS1

protein-coding

methionyl-tRNA synthetase 1, the group of MicroRNA protein coding host genes|Aminoacyl tRNA synthetases, Class I

Gene summary

This gene encodes a member of the class I family of aminoacyl-tRNA synthetases. These enzymes play a critical role in protein biosynthesis by charging tRNAs with their cognate amino acids. The encoded protein is a component of the multi-tRNA synthetase complex and catalyzes the ligation of methionine to tRNA molecules. [provided by RefSeq, Jan 2011]

Previous symbols:
  • MARS

MANE transcript

NM_004990.4

Inheritance

AD, AR

ClinVar variants

P:14U:514B:204

Top phenotype

Interstitial lung and liver disease

gnomAD constraint

pLI —, LoF o/e 0.58

Max pathogenic AF

—

Genomic locus

chr12:57,475,445-57,517,569

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~42.1 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

spastic paraplegia 70, autosomal recessiveLIMITED

Inheritance Pattern: Unknown

Disease ID:MONDO:0957221

Submitter: Labcorp Genetics (formerly Invitae)

Charcot-Marie-Tooth diseaseLIMITED

Inheritance Pattern: AD

Disease ID:MONDO:0015626

Submitter: ClinGen

MARS1, encoding for methionyl-tRNA-transferase, was first reported in relation to ​autosomal dominant axonal Charcot-Marie-Tooth (CMT) ​​in ​2013 (Gonzalez et al., PMID 23729695), in a 45 year old patient with walking difficulties, distal lower limb neuropathic pain and electrophysiological evidence of motor-sensory axonal neuropathy. The same variant was also found in the unaffected mother and in the affected uncle, concluding incomplete penetrance. Evidence supporting this variant include the high conservation of the involved residue across different species and loss of function in an yeast complementation assay. Nevertheless, the mutation, p.Arg618His, is present in 2 out of 251488 alleles in GNOMAD suggesting it is benign. In addition, another amino acid substitution at the same position, p.Arg618Cys, is also present in 3 out of 251488 alleles on GNOMAD suggesting that in humans this amino acid is not well conserved. Three other variants have been reported in humans in relation to CMT (PMIDs 31356216, 24354524, 27717217, 27025386 , 29582526 ); one of them (PMIDs 31356216, p.Ala397Thr) was identified by exome sequencing in a 11 year old patient with diffuse motor neuropathy. Variant level evidence in this case include high conservation of the residue across different species and loss of function in an yeast complementation assay. Segregation of the mutation was limited to two family members and did not include the unaffected father. The other 2 reported variants, p.Pro800Thr and p.Arg737Trp,, have been observed in gnomAD in the population of origin. Of note, biallelic mutations in this gene have been associated with interstitial lung and liver disease, but no clinical features of CMT have been reported in heterozygous carriers or homozygotes. Methionyl-tRNA-transferase belongs to the aminoacyl-tRNA transferase (ARS) family of enzymes. The mechanism by which MARS1 variants may cause CMT is unknown. The presumed haploinsufficiency mechanism in CMT, however, did not bear out in the homozygous patients with interstitial lung disease (PMID: 32833345). In summary, there is only limited to no evidence in support of this gene-disease relationship. ​We do not recommend the testing of this gene in the every-day clinical setting. **Recuration Update**: No new literature evidence was found in 2026 so the classification remains unmodified.

severe early-onset pulmonary alveolar proteinosis due to MARS deficiencyMODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0014206

Submitter: ClinGen

Methionyl-tRNA synthetase 1 (*MARS1*) was first reported in relation to autosomal recessive interstitial lung and liver disease in 2013 (van Meetl et al., PMID: 24103465). Features of disease can include but are not limited to: liver disease, interstitial lung disease, pulmonary alveolar proteinosis, anemia, and developmental delay. Age of onset for all cases in this curation were in either infancy or early childhood. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found differences in the inheritance pattern and phenotypic variability. Therefore, the following disease entities have been split into multiple disease entities, Charcot-Marie-Tooth disease, axonal, type 2U (OMIM: 616280) and Interstitial lung and liver disease (OMIM: 615486). The Spastic paraplegia 70, autosomal recessive (OMIM: 620323) and Trichothiodystrophy 9, nonphotosensitive (OMIM: 619692) entities were not curated due to limited case evidence avialable at the time of curation. The split curation for autosomal dominant Charcot-Marie-Tooth disease, axonal, type 2U (OMIM: 616280) has been curated separately by the Charcot-Marie Tooth GCEP. 16 variants (14 missense, 1single amino acid insertion, and 1 nonsense) that have been reported in 11 probands in 10 publications (PMIDs: 24103465, 25913036, 37936900, 29655802, 30271085, 28148924, 34585293, 32833345, 34496286, 30723866) are included in this curation. The mechanism of pathogenicity appears to be loss of methionyl-tRNA synthetase activity and decreased methionine incorporation (PMIDs 24103465, 25913036). This gene-disease relationship is also supported by expression and biochemical function evidence where in vitro enzyme kinetics show a decrease in funciton for variant protein (PMIDs: 29775242, 23715323). In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen ILD GCEP on the meeting date October 20, 2026 (SOP Version 12).

trichothiodystrophySTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0018053

Submitter: PanelApp Australia

Charcot-Marie-Tooth disease axonal type 2ULIMITED

Inheritance Pattern: AD

Disease ID:MONDO:0014566

Submitter: PanelApp Australia

severe early-onset pulmonary alveolar proteinosis due to MARS deficiencySTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0014206

Submitter: Labcorp Genetics (formerly Invitae)

severe early-onset pulmonary alveolar proteinosis due to MARS deficiencySTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0014206

Submitter: PanelApp Australia

trichothiodystrophy 9, nonphotosensitiveLIMITED

Inheritance Pattern: AR

Disease ID:MONDO:0030518

Submitter: Illumina

Charcot-Marie-Tooth disease axonal type 2USTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0014566

Submitter: Labcorp Genetics (formerly Invitae)

trichothiodystrophy 9, nonphotosensitiveLIMITED

Inheritance Pattern: Unknown

Disease ID:MONDO:0030518

Submitter: Labcorp Genetics (formerly Invitae)

Clinical Genomic Database (CGD)

Interstitial lung and liver diseaseAR

Manifestation: Biochemical; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Hematologic; Neurologic; Pulmonary

Intervention: Hematologic

Rationale: While the condition may involve multiple issues related to medical care, the described individual had transfusion-dependent anemia, and awareness may allow prompt recognition and treatment

Refs: 23729695; 24103465; 24354524; 24482476; 25913036; 33909043; 34585293Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to MARS1 variants in ClinVar

12 Conditions Cataloged
Severe early-onset pulmonary alveolar proteinosis due to MARS deficiencyTotal: 804
Charcot-Marie-Tooth disease axonal type 2UTotal: 803
not specifiedTotal: 252
not providedTotal: 158
MARS1-related disorderTotal: 108
Charcot-Marie-Tooth diseaseTotal: 64
Trichothiodystrophy 9, nonphotosensitiveTotal: 7
Autosomal recessive spastic paraplegia type 70Total: 6

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_004990.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
5
clinvar
177
clinvar
2
clinvar
184
missense
2
clinvar
5
clinvar
437
clinvar
23
clinvar
467
nonsense
1
clinvar
1
clinvar
17
clinvar
19
start loss
1
clinvar
1
frameshift
2
clinvar
3
clinvar
33
clinvar
1
clinvar
39
splice donor/acceptor (+/-2bp)
21
clinvar
1
clinvar
22
Total595142022732

Highest pathogenic variant AF is 0.000027260212

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 87 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_004990.4RefSeqNP_004981.221MANE Select
ENST00000262027.10EnsemblENSP00000262027.521MANE Select
ENST00000537638.6EnsemblENSP00000446168.214Standard
ENST00000545888.6EnsemblENSP00000439307.25Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
marsDanio rerio

Structure: pharyngeal arch 1

Quality: hypoplastic

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Selenocompound metabolism - Homo sapiens (human)
  • Aminoacyl-tRNA biosynthesis - Homo sapiens (human)
  • S-Adenosylhomocysteine (SAH) Hydrolase Deficiency
  • Methionine Metabolism
  • Methionine Adenosyltransferase Deficiency

Biological Process

  • tRNA aminoacylation for protein translation
  • methionyl-tRNA aminoacylation
  • cellular response to starvation
  • rRNA transcription
  • cellular response to insulin stimulus

Molecular Function

  • tRNA binding
  • methionine-tRNA ligase activity
  • ATP binding

Cellular Component

  • nucleolus
  • cytoplasm
  • cytosol
  • membrane
  • aminoacyl-tRNA synthetase multienzyme complex

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000262027
Coding exons
21
Length
42125
Individuals with no LoFs
125617
Homozygous LoFs
0
Heterozygous LoFs
131
Defined
125748
p
0.000521
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense1.144375090.8580.00002915837
Missense (PolyPhen)115171.140.671961960
Synonymous0.1441972000.9870.00001071797
Loss of Function2.913356.60.5830.00000320577

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000860.00086rare
Latino/Admixed American0.000810.00081rare
Ashkenazi Jewish00.0absent
East Asian0.000490.00049rare
Finnish0.000140.00014rare
European (Non-Finnish)0.000550.00055rare
South Asian0.000420.00042rare
Other0.000160.00016rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Catalyzes the specific attachment of an amino acid to its cognate tRNA in a 2 step reaction: the amino acid (AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA. {ECO:0000269|PubMed:11714285}.;
Disease
DISEASE: Interstitial lung and liver disease (ILLD) [MIM:615486]: An autosomal recessive, life-threatening disorder characterized by respiratory insufficiency and progressive liver disease with onset in infancy or early childhood. Clinical features include failure to thrive, hypotonia, intermittent lactic acidosis, aminoaciduria, hypothyroidism, interstitial lung disease, pulmonary alveolar proteinosis, anemia, and liver canalicular cholestasis, steatosis, and iron deposition. {ECO:0000269|PubMed:24103465, ECO:0000269|PubMed:25913036}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Charcot-Marie-Tooth disease 2U (CMT2U) [MIM:616280]: An axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. CMT2U is a slowly progressive, autosomal dominant form characterized by late-adult onset. {ECO:0000269|PubMed:23729695, ECO:0000269|PubMed:24354524}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.502

Intolerance Scores

LoFtool
0.963
RVIS EVS
-0.97
RVIS percentile EVS
8.95

Essentials

Essential (CRISPR)
E
Essential (CRISPR2)
E
Essential (gene trap)
E
Indispensability pred.
E
Indispensability score
0.993

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.